Uncategorised - European Medical Journal

New Prostate Cancer Risk Gene Identified

The investigation began with a comparison between 3,716 PCa patients from Johns Hopkins University, Baltimore, Maryland.

The word spotlight on a blue background

Spotlight: May 2025

Catch up on May’s key pharma news, research updates and policy shifts.

Innovator, Author, and Leader: Interview with Srihari S. Naidu

EMJ spoke with Srihari S. Naidu, who shared insights into his pioneering work in alcohol septal ablation, his contributions as a published…

DBT Outperforms Mammography for Breast Cancer Screening in High-Risk Women

Study shows DBT improves breast cancer screening outcomes in high-risk women, particularly those with dense breast tissue.

Experimental Drug Shows Hopeful Results in Aggressive ALS

Experimental drug jacifusen shows promise for rare ALS, with some patients experiencing unprecedented recovery and stabilisation.

Bradley Monk

Onc Now: Episode 18: What's New from ESGO 2025?

Bradley Monk, Medical Director of Late-Phase Research at Florida Cancer Specialists, shares his insights from ESGO 2025 and landmark studies in gynaecologic oncology.

Breaking the Silence

Update your knowledge of chronic obstructive pulmonary disease (COPD) with this infographic reflecting the latest understanding of…

Type 2 Diabetes Triples COVID-19 Death Risk, Study Finds

Research confirms Type 2 diabetes greatly increases risks of death, severity, and ventilation need in COVID-19 cases.

New Study Investigates Pain in Eosinophilic Esophagitis

The study highlights a potentially critical role for the BDNF-NTRK2 pathway in symptom development.

Lung Function Decline May Begin in Early 20s

New research shows lung function peaks earlier in life and declines steadily without plateau, challenging prior assumptions.